Range
17.88 - 18.62
Vol / Avg.
18.3K/-
Div / Yield
-
52 Wk
- - -
Mkt Cap
491.7M
Payout Ratio
-
Open
18.46
P/E
-
EPS
-0.46
Shares
26.5M
Outstanding
26.5M
Total Float
8.2M
Benzinga - Aug 11, 2021, 12:35PM
Eliem Therapeutics Inc is a clinical-stage biotechnology company. It is focused on developing novel therapies for neuronal excitability disorders to address unmet needs in chronic pain, psychiatry, epilepsy and other disorders of the peripheral and central nervous systems.

Earnings

see more
Q3 2021Est.ActualSurprise
EPS
(EXPECTED)2021-12-13
REV
Q2 2021Est.ActualSurprise
EPS-3.110
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Eliem Therapeutics Questions & Anwsers

Q

How do I buy Eliem Therapeutics (ELYM) stock?

A

You can purchase shares of Eliem Therapeutics (NASDAQ: ELYM) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Eliem Therapeutics's (ELYM) competitors?

A

There are no as such competitors for Eliem Therapeutics.

Q

What is the target price for Eliem Therapeutics (ELYM) stock?

A

The latest price target for Eliem Therapeutics (NASDAQ: ELYM) was reported by Guggenheim on September 7, 2021. The analyst firm set a price target for 32.00 expecting ELYM to rise to within 12 months (a possible 72.79% upside). 3 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Eliem Therapeutics (ELYM)?

A

The stock price for Eliem Therapeutics (NASDAQ: ELYM) is $18.52 last updated Mon Oct 25 2021 20:00:02 GMT+0000 (Coordinated Universal Time).

Q

Does Eliem Therapeutics (ELYM) pay a dividend?

A

There are no upcoming dividends for Eliem Therapeutics.

Q

When is Eliem Therapeutics (NASDAQ:ELYM) reporting earnings?

A

Eliem Therapeutics’s $Q3 earnings are confirmed for after-market on $December 13, 2021.

Q

Is Eliem Therapeutics (ELYM) going to split?

A

There is no upcoming split for Eliem Therapeutics.

Q

What sector and industry does Eliem Therapeutics (ELYM) operate in?

A

Eliem Therapeutics is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.